EVANSVILLE, Ind. (WFIE) - At the end of July, Lilly King officially wrapped up her swimming career, racing her final meet at ...

More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, ...

Rigel's Q2 results highlight soaring revenue and raised guidance for 2025. See more on RIGL stock's growth potential, ...

Drugs to treat ADHD were linked to a reduced risk of suicidal behavior, substance misuse and criminality in the first research of its kind.

Texas Attorney General Ken Paxton filed a lawsuit against Eli Lilly, accusing the drug maker of bribing doctors to prescribe ...

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) is pressing ahead in the weight-loss drug race with the launch of its Phase 2 VENTURE ...

Texas has sued pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe its ...

Last and least, I look at the drug stocks and I can’t believe how awful they really are, with now Eli Lilly last joining the ...

The drugmaker is one step closer to breaking ground on over 200 acres of land in a Houston development that's seeking ...

Eli Lilly is now selling Mounjaro GLP-1 weight loss drugs in India. Rival Novo Nordisk began Indian Wegovy sales in June.

The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.